Press Release
Dimension Bio Secures Commercialization Resource Awards from ReGen Valley Tech Hub
Support includes strategic regulatory, manufacturing, and reimbursement services to accelerate their BioNidum™-empowered cell therapies
CHICAGO, Illinois, USA – August 27, 2025 – Dimension Bio, a biotechnology company pioneering regenerative therapeutics, today announced it has been selected to receive commercialization resource awards from the ReGen Valley Tech Hub. The support spans three critical areas - Strategic Regulatory Services, Manufacturing Strategy, and Reimbursement Strategy - aimed at accelerating the path of its implantable cell therapy for liver failure from development to market. Dimension Bio will engage as a partner in the Regen Valley Tech Hub, working alongside the Advanced Regenerative Manufacturing Institute (ARMI), to strategically utilize commercialization resources that support growth and innovation.
Led by ARMI, the ReGen Valley Tech Hub is designed to make New Hampshire a global leader in biofabrication, producing cost-effective regenerative therapies that address chronic disease and organ failure. The Tech Hub is backed by approximately $44 million in EDA implementation funding to expand commercialization capacity, workforce training, and advanced manufacturing facilities across the region.
“Bringing advanced therapies from breakthrough to bedside requires a coordinated approach, including regulation, manufacturing, and market access,” said Caralynn Nowinski Collens, M.D., Co-Founder, and Chief Executive Officer of Dimension Bio. “The ReGen Valley Tech Hub resources allow us to further de-risk these functions in parallel, shortening timelines for the patients who desperately need our liver-support therapy.”
Dimension Bio is unlocking the next generation of regenerative medicine with its proprietary BioNidum™ system that overcomes key limitations in cell therapy delivery. Their lead program harnesses this technology to treat patients with liver failure by creating a first-in-class implantable cell therapy that offers immediate and durable hepatic function – bridging patients through the acute crisis to recovery or transplant.
+ About Dimension Bio
Dimension Bio is a biotechnology company pioneering regenerative therapeutics. We design lifesaving solutions that restore organ function lost to disease, trauma or aging. Our bioinspired cell delivery system, BioNidum™, fuses materials science, 3D-printing, and digital manufacturing to transform cells into implantable, tissue-like therapies.
By providing a three-dimensional architecture that promotes rapid vascularization and seamless tissue integration, our tissue therapeutics create the conditions cells need to survive, function, and persist. The result is a more durable and effective therapeutic response—unlocking the curative potential of cell therapies.
Our lead program targets liver failure, providing immediate supplemental liver function to stabilize patients in crisis. By enabling the native liver to recover, it offers an alternative to transplant and fills a critical gap for those with limited treatment options.
+ About the ReGen Valley Tech Hub
Designated by the U.S. Economic Development Administration’s Tech Hubs Program in 2023, the ReGen Valley Tech Hub is a consortium of more than 40 organizations coordinated by ARMI. Its goal is to secure domestic leadership in biofabrication by scaling commercialization resources, expanding advanced manufacturing infrastructure, and nurturing a skilled workforce in New Hampshire’s Manchester-Nashua region.